Close Menu
    Latest Posts

    GLP-1 implant from Vivani Medical aims to help patients stay on treatment

    July 12, 2026

    Goldman Sachs picks its favorite Chinese AI models

    July 12, 2026

    Prediction markets spark insider trading fears. How firms are responding

    July 12, 2026
    Facebook X (Twitter) Instagram
    Trending
    • GLP-1 implant from Vivani Medical aims to help patients stay on treatment
    • Goldman Sachs picks its favorite Chinese AI models
    • Prediction markets spark insider trading fears. How firms are responding
    • Top analysts are confident about these 3 stocks for the long haul
    • Oil prices rise, stock futures dip after latest flare-up of strikes between U.S. and Iran
    • Cattle Extending Losses to Friday
    • Charges against man accused of running crypto fraud will be dropped
    • Vietnam tracks towards credit growth target
    Facebook X (Twitter) Instagram
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Monday, July 13
    • Home
    • Banking
    • Business
    • Crypto
    • Economy
    • Fintech
    • Investing
    • Markets
    • Stocks
    MoneyLister – Smart Investing & Financial NewsMoneyLister – Smart Investing & Financial News
    Home»Stocks»Zymeworks Inc. Q4 Loss Widens
    Stocks

    Zymeworks Inc. Q4 Loss Widens

    AdminBy AdminMarch 2, 2026No Comments1 Min Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email VKontakte Telegram
    Higher Open Called For Taiwan Stock Market
    Share
    Facebook Twitter Pinterest Email Copy Link

    (RTTNews) – Zymeworks Inc. (ZYME) announced Loss for its fourth quarter of -$41.209 million

    The company’s bottom line came in at -$41.209 million, or -$0.55 per share. This compares with -$23.506 million, or -$0.31 per share, last year.

    The company’s revenue for the period fell 91.9% to $2.5 million from $31 million last year.

    Zymeworks Inc. earnings at a glance (GAAP) :

    -Earnings: -$41.209 Mln. vs. -$23.506 Mln. last year.
    -EPS: -$0.55 vs. -$0.31 last year.
    -Revenue: $2.5 Mln vs. $31 Mln last year.

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    loss Widens Zymeworks
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Telegram Copy Link
    Admin
    • Website

    Related Posts

    Stocks

    Cattle Extending Losses to Friday

    July 12, 2026
    Stocks

    My insurance company said my roof lost a few tiles. Loss adjusters found $10,000 in storm damage. How could this happen?

    July 11, 2026
    Stocks

    Credo Technology: An Undervalued Leader in AI Optics Trading at a 47% Discount

    July 11, 2026
    Stocks

    Freeport-McMoran: Is the Copper Stock Ready to Explode on Data Center Demand?

    July 10, 2026
    Stocks

    Cathie Wood Sold $8 Million of AMD Stock in a Single Day

    July 9, 2026
    Stocks

    Plot twist: Gen Z is buying houses after all. Here’s how they’re doing it.

    July 8, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    GLP-1 implant from Vivani Medical aims to help patients stay on treatment

    July 12, 2026

    Goldman Sachs picks its favorite Chinese AI models

    July 12, 2026

    Prediction markets spark insider trading fears. How firms are responding

    July 12, 2026

    Top analysts are confident about these 3 stocks for the long haul

    July 12, 2026
    Latest Posts

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    About Us

    Welcome to MoneyLister.com — your trusted source for reliable insights in the world of finance, investing, and digital assets.

    At MoneyLister, our mission is simple: to make complex financial topics easy to understand and accessible to everyone. Whether you're a beginner exploring cryptocurrency, an investor tracking the stock market, or a professional staying updated on global business trends, we provide clear, informative, and up-to-date content to help you stay ahead.

    Facebook X (Twitter) Instagram Pinterest YouTube
    Latest Posts

    GLP-1 implant from Vivani Medical aims to help patients stay on treatment

    July 12, 2026

    Goldman Sachs picks its favorite Chinese AI models

    July 12, 2026

    Prediction markets spark insider trading fears. How firms are responding

    July 12, 2026
    Recent Posts
    • GLP-1 implant from Vivani Medical aims to help patients stay on treatment
    • Goldman Sachs picks its favorite Chinese AI models
    • Prediction markets spark insider trading fears. How firms are responding
    • Top analysts are confident about these 3 stocks for the long haul
    • Oil prices rise, stock futures dip after latest flare-up of strikes between U.S. and Iran
    © 2026 moneylister. Designed by Pro.
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.